Comparison of anticoagulation and thrombolysis treatments in a rat model of superior sagittal sinus thrombosis

References

• Einhaupl K, Bousser MG, de Bruijn SF, EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006;13:553–9.
   PubMed Web of Science ®Google Scholar
• Wasay M, Bakshi R, Kojan S, Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 2001;32:2310–7.
   PubMed Web of Science ®Google Scholar
• Ehtisham A, Stern BJ. Cerebral venous thrombosis: a review. Neurologist 2006;12:32–8.
   PubMedGoogle Scholar
• Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791–8.
   PubMed Web of Science ®Google Scholar
• Bousser MG. Cerebral venous thrombosis. ed. London: WB Saunders; 1999.
   Google Scholar
• Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992;10:87–111.
   PubMed Web of Science ®Google Scholar
• Ito K, Tsugane R, Ikeda A, Cerebral hemodynamics and histological changes following acute cerebral venous occlusion in cats. Tokai J Exp Clin Med 1997;22:83–93.
   Google Scholar
• Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke 1999;30:481–3.
   PubMedGoogle Scholar
• Benveniste R, Patel AB, Post KD. Management of cerebral venous sinus thrombosis. Neurosurg Q 2004;14:27–35.
   Google Scholar
• de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psych 2001;70: 105–8.
   Google Scholar
• Rother J, Waggie K, van Bruggen N, Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging. J Cereb Blood Flow Metab 1996;16:1353–61.
   Google Scholar
• Fries G, Wallenfang T, Kempski O, Brain oedema and intracranial pressure in superior sagittal sinus balloon occlusion. An experimental study in pigs. Acta Neurochir Suppl (Wien) 1990;51:231–2.
   Google Scholar
• Baumgartner RW, Studer A, Arnold M, Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psych 2003;74:459–61.
   Google Scholar
• Soleau SW, Schmidt R, Stevens S, Extensive experience with dural sinus thrombosis. Neurosurgery 2003;52:534–44; discussion 42–4.
   Google Scholar
• Rottger C, Madlener K, Heil M, Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis. Stroke 2005;36:841–6.
   PubMed Web of Science ®Google Scholar
• Andeweg J. The anatomy of collateral venous flow from the brain and its value in aetiological interpretation of intracranial pathology. Neuroradiology 1996;38:621–8.
   Google Scholar
• Nakase H, Shin Y, Nakagawa I, Clinical features of postoperative cerebral venous infarction. Acta Neurochir (Wien) 2005;147:621–6; discussion 6.
   PubMedGoogle Scholar
• Wang J, Ji X, Ling F, A new model of reversible superior sagittal sinus thrombosis in rats. Brain Res 2007;1181:118–24.
   Google Scholar
• Guarini S. A highly reproducible model of arterial thrombosis in rats. J Pharmacol Toxicol Methods 1996;35:101–5.
   Google Scholar
• Mousa SA. In vivo models for the evaluation of antithrombotics and thrombolytics. Methods Mol Biol 2010;663:29–107.
   Google Scholar
• Ramani M, van Groen T, Kadish I, Neurodevelopmental impairment following neonatal hyperoxia in the mouse. Neurobiol Dis 2013;50:69–75.
   Google Scholar
• Kim Y, Nakase H, Nagata K, Observation of arterial and venous thrombus formation by scanning and transmission electron microscopy. Acta Neurochir (Wien) 2004;146:45–51; discussion.
   Google Scholar
• Ferro JM, Canhao P, Stam J, Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664–70.
   PubMed Web of Science ®Google Scholar
• Einhaupl KM, Villringer A, Meister W, Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597–600.
   PubMed Web of Science ®Google Scholar
• de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484–8.
   PubMed Web of Science ®Google Scholar
• Nagaraja D, Rao B, Taly AB, Subhash MN. Randomized controlled trial of heparin in puerperal cerebral venous/sinus thrombosis. Nimhans J 1995;13:111–5.
   Google Scholar
• Philips MF, Bagley LJ, Sinson GP, Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999;90:65–71.
   PubMedGoogle Scholar
• Ciccone A, Canhao P, Falcao F, Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 2004;(1): CD003693.
   Google Scholar
• Coutinho JM, Ferro JM, Zuurbier SM, Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke 2013;8(2):135–40.
   Google Scholar
• Lopez-Pelaez MF, Millan JM, de Vergas J. Fatal cerebral venous sinus thrombosis as major complication of metastatic cervical mass: computed tomography and magnetic resonance findings. J Laryngol Otol 2000;114:798–801.
   Google Scholar
• Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol 2004;251:11–23.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Heimann A, Kempski O. Microcirculatory alterations in a Mongolian gerbil sinus-vein thrombosis model. J Clin Neurosci 2001;8 Suppl 1:97–105.
   Google Scholar
• Kim DE, Schellingerhout D, Jaffer FA, Nearinfrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis. J Cereb Blood Flow Metab 2005;25: 226–33.
   Google Scholar
• Gavins F, Yilmaz G, Granger DN. The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation 2007;14:667–81.
   PubMed Web of Science ®Google Scholar
• Nagai M, Yilmaz CE, Kirchhofer D, Role of coagulation factors in cerebral venous sinus and cerebral microvascular thrombosis. Neurosurgery 2010;66(3):560–5; discussion 565–6.
   Google Scholar
• Li G, Zeng X, Ji T, A new thrombosis model of the superior sagittal sinus involving cortical veins. World Neurosurg 2012. (Epub ahead of print).
   Google Scholar
• Nagai M, Terao S, Yilmaz G, Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis. Stroke 2010;41(1): 147–52.
   Google Scholar